LOGIN TO YOUR ACCOUNT

Username
Password
Remember Me
Or use your Academic/Social account:

CREATE AN ACCOUNT

Or use your Academic/Social account:

Congratulations!

You have just completed your registration at OpenAire.

Before you can login to the site, you will need to activate your account. An e-mail will be sent to you with the proper instructions.

Important!

Please note that this site is currently undergoing Beta testing.
Any new content you create is not guaranteed to be present to the final version of the site upon release.

Thank you for your patience,
OpenAire Dev Team.

Close This Message

CREATE AN ACCOUNT

Name:
Username:
Password:
Verify Password:
E-mail:
Verify E-mail:
*All Fields Are Required.
Please Verify You Are Human:
fbtwitterlinkedinvimeoflicker grey 14rssslideshare1
Lawson, J.S.; Syme, H.M.; Wheeler-Jones, C.P.D.; Elliott, J. (2016)
Publisher: Elsevier BV
Journal: The Veterinary Journal
Languages: English
Types: Article
Subjects: Renal, Cytokine, veterinary(all), Urine, Cat, Animal Science and Zoology, Fibrosis, Article
The cytokine transforming growth factor beta 1 (TGF-?1) has been widely implicated in the development and progression of renal fibrosis in chronic kidney disease (CKD) in humans and in experimental models. The aims of this study were to assess the association between urinary active TGF-?1 and (a) development of CKD in a cross-sectional study, (b) deterioration of renal function over 1 year in a longitudinal study, and (c) renal histopathological parameters in cats. A human active TGF-?1 ELISA was validated for use in feline urine. Cross-sectional analysis revealed no significant difference in urinary active TGF-?1:creatinine ratio (aTGF-?1:UCr) between groups with differing renal function. Longitudinally, non-azotaemic cats that developed CKD demonstrated a significant (P?=?0.028) increase in aTGF-?1:UCr approximately 6 months before the development of azotaemia, which remained elevated (P?=?0.046) at diagnosis (approximately 12 months prior, 8.4?pg/mg; approximately 6 months prior, 22.2?pg/mg; at CKD diagnosis, 24.6?pg/mg). In the histopathology study, aTGF-?1:UCr was significantly higher in cats with moderate (P?=?0.02) and diffuse (P?=?0.005) renal fibrosis than in cats without fibrosis. Cats with moderate renal inflammation had significantly higher urinary active aTGF-?1 concentrations than cats with mild (P?=?0.035) or no inflammatory change (P?=?0.004). The parameter aTGF-?1:UCr was independently associated with Log urine protein:creatinine ratio in a multivariable analysis of clinicopathological parameters and interstitial fibrosis score in a multivariable analysis of histopathological features. These results suggest that urinary aTGF-?1 reflects the severity of renal pathology. Increases in urinary aTGF-?1 followed longitudinally in individual cats may indicate the development of CKD.

Share - Bookmark

Cite this article